This systematic reviews aims to assess whether vitamin D and calcium supplements reduce the risk for cardiovascular disease in adults (without renal disease). The authors were limited by a small number of heterogeneous studies where cardiovascular disease was not the primary outcome. They concluded that vitamin D supplementation at moderate to high doses may reduce CVD risk, however, calcium supplements seem to have minimal cardiovascular effects.
- Interventions for bone disease in children with chronic kidney disease.
- Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the folic acid for vascular outcome reduction in transplantation trial
- Empagliflozin and Clinical Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease